Detailed information for compound 1537354

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 314.766 | Formula: C17H15ClN2O2
  • H donors: 0 H acceptors: 2 LogP: 4.35 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOC(=O)c1nn(c2c1cccc2)Cc1ccc(cc1)Cl
  • InChi: 1S/C17H15ClN2O2/c1-2-22-17(21)16-14-5-3-4-6-15(14)20(19-16)11-12-7-9-13(18)10-8-12/h3-10H,2,11H2,1H3
  • InChiKey: JNQJQQIBOONACK-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Treponema pallidum flavodoxin 0.0169 0.3504 1
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.0441 1 1
Trichomonas vaginalis sulfite reductase, putative 0.0441 1 1
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0169 0.3504 0.2654
Mycobacterium tuberculosis Possible electron transfer protein FdxB 0.005 0.0676 0.5
Mycobacterium tuberculosis Probable monooxygenase 0.005 0.0676 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.005 0.0676 0.5
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.0441 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0219 0.47 1
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0272 0.5976 0.5976
Schistosoma mansoni NADH-cytochrome B5 reductase 0.005 0.0676 0.0676
Trypanosoma brucei S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0169 0.3504 0.3033
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0169 0.3504 0.2654
Schistosoma mansoni cytochrome B5 0.005 0.0676 0.0676
Echinococcus multilocularis cytochrome b5 reductase 4 0.005 0.0676 0.0676
Toxoplasma gondii flavodoxin domain-containing protein 0.0219 0.47 1
Mycobacterium tuberculosis Possible oxygenase 0.005 0.0676 0.5
Giardia lamblia Hypothetical protein 0.0391 0.8804 1
Loa Loa (eye worm) diaphorase 0.005 0.0676 0.0676
Echinococcus granulosus methionine synthase reductase 0.0272 0.5976 0.5976
Brugia malayi Cytochrome b5-like Heme/Steroid binding domain containing protein 0.005 0.0676 0.0676
Echinococcus granulosus cytochrome b5 reductase 4 0.005 0.0676 0.0676
Echinococcus granulosus cytochrome b5 reductase 4 0.005 0.0676 0.0676
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.0441 1 1
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0441 1 1
Schistosoma mansoni voltage-gated potassium channel 0.0082 0.1441 0.1441
Loa Loa (eye worm) cytochrome b5 reductase 4 0.005 0.0676 0.0676
Schistosoma mansoni cytochrome P450 reductase 0.0441 1 1
Plasmodium falciparum nitric oxide synthase, putative 0.0441 1 1
Loa Loa (eye worm) FAD binding domain-containing protein 0.0272 0.5976 0.5976
Plasmodium falciparum S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0169 0.3504 0.3033
Mycobacterium tuberculosis Hypothetical oxidoreductase 0.005 0.0676 0.5
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.0075 0.1276 0.1276
Schistosoma mansoni diflavin oxidoreductase 0.0219 0.47 0.47
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0169 0.3504 0.3033
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.0441 1 1
Plasmodium vivax flavodoxin domain containing protein 0.0391 0.8804 0.8717
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0075 0.1276 0.1276
Plasmodium vivax hypothetical protein, conserved 0.0169 0.3504 0.3033
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0169 0.3504 0.2654
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.0441 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0169 0.3504 0.5
Entamoeba histolytica type A flavoprotein, putative 0.0169 0.3504 0.5
Brugia malayi diaphorase 0.005 0.0676 0.0676
Onchocerca volvulus 0.005 0.0676 0.5
Echinococcus multilocularis methionine synthase reductase 0.0272 0.5976 0.5976
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0169 0.3504 0.2654
Entamoeba histolytica type A flavoprotein, putative 0.0169 0.3504 0.5
Schistosoma mansoni voltage-gated potassium channel 0.0082 0.1441 0.1441
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0441 1 1
Trypanosoma cruzi NADPH--cytochrome P450 reductase, putative 0.0169 0.3504 0.3033
Plasmodium falciparum NADPH--cytochrome P450 reductase, putative 0.0169 0.3504 0.3033
Loa Loa (eye worm) hypothetical protein 0.0441 1 1
Echinococcus granulosus NADPH cytochrome P450 reductase 0.0441 1 1
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.0075 0.1276 0.1276
Loa Loa (eye worm) flavodoxin family protein 0.0169 0.3504 0.3504
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0441 1 1
Trypanosoma cruzi p450 reductase, putative 0.0441 1 1
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.0441 1 1
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.0441 1 1
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.0391 0.8804 0.8647
Loa Loa (eye worm) hypothetical protein 0.0065 0.1038 0.1038
Leishmania major cytochrome P450 reductase, putative 0.0391 0.8804 0.8717
Echinococcus multilocularis NADH cytochrome b5 reductase 3 0.005 0.0676 0.0676
Leishmania major p450 reductase, putative 0.0441 1 1
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0075 0.1276 0.1276
Brugia malayi FAD binding domain containing protein 0.0272 0.5976 0.5976
Entamoeba histolytica type A flavoprotein, putative 0.0169 0.3504 0.5
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.0441 1 1
Leishmania major hypothetical protein, conserved 0.0169 0.3504 0.3033
Brugia malayi FAD binding domain containing protein 0.0441 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0169 0.3504 0.5
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.0441 1 1
Giardia lamblia Nitric oxide synthase, inducible 0.0391 0.8804 1
Chlamydia trachomatis sulfite reductase 0.0272 0.5976 1
Schistosoma mansoni NADPH flavin oxidoreductase 0.0222 0.478 0.478
Loa Loa (eye worm) FAD binding domain-containing protein 0.0441 1 1
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0441 1 1
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0169 0.3504 0.3033
Echinococcus granulosus NADH cytochrome b5 reductase 3 0.005 0.0676 0.0676
Brugia malayi flavodoxin family protein 0.0169 0.3504 0.3504

Activities

Activity type Activity value Assay description Source Reference
AC50 (functional) = 39.04 uM PUBCHEM_BIOASSAY: Antifungal Drug Resistance - Mammalian Cell Toxicity Measured in Cell-Based System Using Plate Reader - 2037-04_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2007] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.